Advertisement

NVST

Envista Holdings Corporation

Healthcare · USD

Set alert

Price alert · NVST

All alert types
23.51 USD -1.10 -4.47%
As of Oct 30, 2026 Extended hours 23.51 0.00%
Bid
23.47 × 300
Ask
23.49 × 500
23.40 Day range 24.90
18.95 52-week range 30.26
YTD
+8.29%
1 year
+16.73%
Open
24.72
Prev close
24.61
Mkt cap
3.78B
Vol
3.73M
Avg vol
2.88M
EPS
0.58
P/E
40.53
Div yield
0.00%
More statistics
Low
23.40
High
24.90
Forward P/E
14.17
Beta
0.89
Short ratio
3.29
Inst. own
120.19%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
24.66
200-d avg
25.74
1y target
28.69

5D chart

Chart tools
Interval
NVST five-day price chart23.423.824.224.524.9Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
3.77B
Enterprise value
4.42B
Trailing P/E
40.52
Forward P/E
14.17
PEG ratio
0.00
Price / sales
1.32
Price / book
1.23
EPS (TTM)
0.58
Beta
0.89
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
3.33%
Revenue (TTM)
2.86B
Revenue growth
7.10%
Free cash flow
267.89M
Total cash
1.13B
Total debt
1.59B
Return on equity
3.06%
Shares outstanding
160.62M
Short % of float
6.83%
50-day average
24.66
200-day average
25.74

Analyst view

Consensus: buy

Buy
Price target (mean) 28.69 +22.0% upside
Target (low)
23.00
Target (mean)
28.69
Target (high)
34.00
Ratings (0m) 15 7 buy · 8 hold · 0 sell
  • Strong buy2
  • Buy5
  • Hold8
  • Sell0
  • Strong sell0

Next earnings

Nov 4, 2026

Expected Nov 4, 2026. Consensus EPS estimate 0.35596.

Earnings history

Financials — quick view

All financials
NVST Revenue — quarterly 730.50M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
NVST Net income — quarterly 53.70M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
NVST EPS — quarterly 0.33
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

NVST recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2026Oct 3, 20260.3561———
Aug 5, 2026Jul 3, 20260.33530.41+0.07+22.28%
May 6, 2026Apr 3, 20260.310.36+0.05+16.13%
Feb 5, 2026Dec 31, 20250.320.38+0.06+18.75%
Oct 29, 2025Sep 26, 20250.270.32+0.05+18.52%
Jul 31, 2025Jun 27, 20250.240.26+0.02+8.33%

Upgrades / downgrades

NVST analyst upgrades and downgrades
DateFirmActionFromTo
Oct 15, 2026BairddownOutperformNeutral
Oct 14, 2026Leerink PartnersmainOutperformOutperform
Oct 9, 2026Piper SandlermainNeutralNeutral
Sep 28, 2026BMO CapitalmainMarket PerformMarket Perform
Sep 18, 2026Piper SandlerreitNeutralNeutral
Sep 18, 2026UBSmainNeutralNeutral

About Envista Holdings Corporation

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on NVST — it syncs with the Stock Master app.

Insider holders

NVST insider holders
InsiderRelationLatest transactionDateShares held
ACURIO VERONICAOfficerStock Award(Grant)Feb 24, 202656,516
CARRUTHERS WENDYDirectorStock Award(Grant)May 18, 202659,940
HAMMES ERIC D.Chief Financial OfficerStock Award(Grant)Feb 24, 2026110,798
HUENNEKENS R SCOTTDirectorStock Award(Grant)May 18, 202682,105
HULIT BARBARA BDirectorStock Award(Grant)Jun 9, 202579,820
KAABI FAEZ COfficerStock Award(Grant)Feb 24, 202658,552

Institution ownership

NVST institution ownership
Holder% heldSharesValueReported
Blackrock Inc.11.48%18,437,542433.28MJun 29, 2026
Ariel Investments, LLC6.11%9,818,177230.73MJun 29, 2026
Dimensional Fund Advisors LP5.96%9,566,949224.82MJun 29, 2026
Vanguard Portfolio Management LLC4.66%7,487,670175.96MJun 29, 2026
Vanguard Capital Management LLC4.57%7,337,916172.44MJun 29, 2026
Morgan Stanley4.01%6,436,043151.25MJun 29, 2026

Fund ownership

NVST fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Mid-Cap ETF3.56%5,715,451134.31MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.21%5,158,976121.24MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.32%3,733,85987.75MJun 29, 2026
Ariel Investment Trust-Ariel Fund2.11%3,384,35979.53MJun 29, 2026
Eaton Vance Growth Trust-Eaton Vance Atlanta Capital SMID-Cap Fund2.11%3,389,82479.66MJun 29, 2026
UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd.1.86%2,983,70170.12MJun 29, 2026
Advertisement